Verbio stock closed at €30.8 on Thursday, roughly flat over the past week, while the story in the numbers looks far less calm. The quarter that just landed shows Q4 basic earnings per share of €0.65 and net income of €41.6m, capping a year in which the business moved from losses to a reported profit on a trailing basis.
For a company often treated as a high multiple bet on future biofuel cash flows, this release reflects profitability catching up with the narrative. The key question now is how durable that earnings power proves as the new fiscal year unfolds.
If you are interested in Verbio's shift from losses to a reported trailing profit but prefer companies where profitability and balance sheet strength already align, take a look at our curated list of list of solid balance sheet and fundamentals stocks (200 results)
Prefer clean charts over scrolling through dense tables and long reports on Verbio? See a full visual breakdown of Verbio's financial profile, with a clear view of its valuation picture, in our company report for Verbio.
Bulls argue Verbio is a leveraged play on tighter EU greenhouse gas quota supply and higher quality growth from integrated biorefineries. The latest year gives that view some concrete wins. EBITDA of €193.9m, up from a prior loss-making period, sits alongside €78m of free cash flow and a cut in net debt to €91.5m. That points to the integrated model actually feeding cash into the balance sheet rather than just soaking up capex.
The thesis also leans on Nevada and higher margin projects. Nevada’s ramp contributed to a jump in biomethane volumes and helped drive group Q4 EBITDA to €88m, a sharp swing from a loss a year earlier. Management flagged the Bitterfeld ethenolysis unit as entering start up, with presold specialty volumes. That means the promised new profit stream is now moving from slide deck to physical plant, even if commercial proof over a full year is still pending.
Compare Verbio’s new profit stream and higher EBITDA with what institutional models are currently incorporating. See the consensus price target analysis for VerbioVerbio critics argue that biofuels face structural demand decline as electrification spreads, with earnings increasingly tied to fragile regulation and volatile greenhouse gas quota prices. This set of results does not settle that argument. EBITDA of €193.9m and a strong Q4 lean heavily on quota price recovery and a €19m impairment reversal on quota inventories. That points to a business model still highly geared to policy design and trading mechanics rather than solely to underlying fuel use.
Concerns about feedstock and policy risk also find some backing. Management openly guides for softer biodiesel margins and flags rapeseed oil cost pressure, while RED III and German quota rules are presented as key earnings drivers. Nevada and biomethane growth help challenge the idea of an entirely shrinking market, yet long term demand erosion from electric vehicles is not really tested by one strong year. Bears do not get disproved here. They just lose the insolvency fear.
With Verbio now on a P/E of 30.8x and a history of sharply falling earnings before this profit rebound, investors need to verify how resilient its liquidity and balance sheet really are. Analyze the full financial health analysis of Verbio stock.Verbio just moved from losses to a reported trailing profit, which can make timing an entry tricky when sentiment and earnings are both shifting. Register for free with Simply Wall St and add Verbio to your Watchlist to track share price against fair value and watch how new quarters reshape the picture. After you decide to take a position, keep the noise down and focus on the key updates that matter to your holdings through the Portfolio Command Center. Round it out by using the Community to see how other investors are interpreting the latest numbers so you can spot potential catalysts or risks early and stay ahead of the market.
Fresh opportunities do not wait. Some charts are already breaking out while others are dropping before the crowd catches on. Scan these under the radar lists and explore them early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com